Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2568790rdf:typepubmed:Citationlld:pubmed
pubmed-article:2568790lifeskim:mentionsumls-concept:C0024290lld:lifeskim
pubmed-article:2568790lifeskim:mentionsumls-concept:C0439852lld:lifeskim
pubmed-article:2568790lifeskim:mentionsumls-concept:C0123865lld:lifeskim
pubmed-article:2568790pubmed:dateCreated1989-8-17lld:pubmed
pubmed-article:2568790pubmed:abstractTextIotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.lld:pubmed
pubmed-article:2568790pubmed:languageenglld:pubmed
pubmed-article:2568790pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568790pubmed:citationSubsetIMlld:pubmed
pubmed-article:2568790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2568790pubmed:statusMEDLINElld:pubmed
pubmed-article:2568790pubmed:issn0178-4609lld:pubmed
pubmed-article:2568790pubmed:authorpubmed-author:PartschHHlld:pubmed
pubmed-article:2568790pubmed:authorpubmed-author:StöberlCClld:pubmed
pubmed-article:2568790pubmed:authorpubmed-author:WruhsMMlld:pubmed
pubmed-article:2568790pubmed:authorpubmed-author:Wenzel-HoraB...lld:pubmed
pubmed-article:2568790pubmed:issnTypePrintlld:pubmed
pubmed-article:2568790pubmed:volume128lld:pubmed
pubmed-article:2568790pubmed:ownerNLMlld:pubmed
pubmed-article:2568790pubmed:authorsCompleteYlld:pubmed
pubmed-article:2568790pubmed:pagination178-81lld:pubmed
pubmed-article:2568790pubmed:dateRevised2008-2-26lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:meshHeadingpubmed-meshheading:2568790-...lld:pubmed
pubmed-article:2568790pubmed:year1989lld:pubmed
pubmed-article:2568790pubmed:articleTitleIndirect lymphography with iotrolan.lld:pubmed
pubmed-article:2568790pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2568790pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2568790pubmed:publicationTypeComparative Studylld:pubmed